Drugs / GRASS
last change Apr 2022 re-read 2 minutes ago

GRASS

Developed for
hypersensitivity reaction disease

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT05119751 Comparator Oct 2021 → Apr 2022 hypersensitivity reaction disease Clinique Spécialisée en Allergies de la Capitale Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as GRASS ClinicalTrials.gov intervention name — accepted as the source's own label NCT05119751